Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. The company reported quarterly sales of $20.884 million which beat the analyst consensus estimate of $20.164 million by 3.57 percent. This is a 36.53 percent decrease over sales of $32.904 million the same period last year.